| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | eltrombopag | FAERS: 27 | US FAERS | |
| 2 | Ruxolitinib phosphate | FAERS: 6 | US FAERS | |
| 3 | Imatinib Mesylate | FAERS: 5 | US FAERS | |
| 4 | Imatinib Mesylate | FAERS: 4 | US FAERS | |
| 5 | eltrombopag | FAERS: 4 | US FAERS | |
| 6 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 3 | US FAERS | |
| 7 | Azacitidine | FAERS: 2 | US FAERS | |
| 8 | Tacrolimus | FAERS: 2 | US FAERS | |
| 9 | Epoprostenol | FAERS: 1 | US FAERS | |
| 10 | Methotrexate | FAERS: 1 | US FAERS | |
| 11 | anagrelide | FAERS: 1 | US FAERS | |
| 12 | bosutinib | FAERS: 1 | US FAERS | |
| 13 | venetoclax | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.